Evidence map›Paper›PMID 41938678›Full record

ArticleCureus2026

Delayed Diagnosis of Suspected Osteogenesis Imperfecta in a Young Adult with Recurrent Low-Energy Fractures: A Case Report.

Salma Drari, Zineb Baba, Ahmed Mougui, Imane El Bouchti

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Salma DrariRheumatology, Hospital Arrazi, Centre Hospitalier Universitaire (CHU) Mohammed VI, Faculté de Médecine et de Pharmacie de Marrakech (FMPM), Université Cadi Ayyad (UCA), Marrakech, MAR.
Zineb BabaRheumatology, Hospital Arrazi, Centre Hospitalier Universitaire (CHU) Mohammed VI, Faculté de Médecine et de Pharmacie de Marrakech (FMPM), Université Cadi Ayyad (UCA), Marrakech, MAR.
Ahmed MouguiRheumatology, Hospital Arrazi, Centre Hospitalier Universitaire (CHU) Mohammed VI, Faculté de Médecine et de Pharmacie de Marrakech (FMPM), Université Cadi Ayyad (UCA), Marrakech, MAR.
Imane El BouchtiRheumatology, Hospital Arrazi, Centre Hospitalier Universitaire (CHU) Mohammed VI, Faculté de Médecine et de Pharmacie de Marrakech (FMPM), Université Cadi Ayyad (UCA), Marrakech, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteogenesis imperfecta (OI) is a rare heritable connective tissue disorder characterized by bone fragility and heterogeneous clinical presentation. Mild phenotypes may remain undiagnosed for prolonged periods, particularly when clinical manifestations are subtle or overlooked. We report the case of a 19-year-old man with a history of recurrent low-energy fractures since the age of eight. The patient sustained multiple fractures involving long bones, associated with progressive deformities of the lower extremities. Notably, no etiological workup had been performed during childhood. On admission, physical examination revealed blue sclerae. A positive family history was identified, with recurrent fractures reported in two maternal uncles. Based on the clinical presentation and family history, a diagnosis of type I osteogenesis imperfecta was established. This case underscores the critical importance of early recognition of suggestive clinical features in children presenting with recurrent fractures. Improved clinician awareness may help reduce diagnostic delays, prevent complications, and enable timely genetic counseling and appropriate multidisciplinary management.

Indexed as

biphosphonate therapybone fragilitygenetic bone disorderosteogenesis imperfectayoung adult

Identifiers

PMID41938678
PMCPMC13050301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.